31.
When carrying out the risk assessment special consideration shall be given to toxicity data derived from observations of human exposure where such data are available, e.g. information gained from manufacture, from poison centres or epidemiology surveys.
← anx_VI__cpt_1__cpt_3__cpt_2__cpt_1__point_30__text_1 · All articles · anx_VI__cpt_1__cpt_3__cpt_2__cpt_1__point_31__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-10-29 · Text as adopted (Official Journal); later amendments are not incorporated in this text.